80 Participants Needed

Exoskeleton-Assisted Movement for Stroke

GH
Jose Pons, Ph.D profile photo
Overseen ByJose Pons, Ph.D
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are taking medications that influence brain function, you may not be eligible to participate.

What data supports the effectiveness of the treatment Real-time Neuromuscular Control of Exoskeletons for stroke patients?

Research shows that exoskeletons can help stroke patients improve their walking and arm movements by providing support and assistance. Studies have found that these devices can safely aid in movement without causing stress or pain, and they can help therapists identify and address muscle weaknesses and coordination issues.12345

Is exoskeleton-assisted movement safe for stroke rehabilitation?

Clinical trials show that powered robotic exoskeletons can be used safely for gait training in stroke patients, with no adverse effects reported in studies involving both lower-limb and upper-limb exoskeletons.12467

How does the Real-time Neuromuscular Control of Exoskeletons treatment differ from other stroke treatments?

This treatment is unique because it uses real-time neuromuscular control to assist movement, relying on the patient's own muscle signals to guide the exoskeleton. This approach enhances the patient's active participation in rehabilitation, unlike traditional therapies that may not integrate real-time feedback from muscle activity.458910

What is the purpose of this trial?

The purpose of this study is to develop a real-time controller for exoskeletons using neural information embedded in human musculature. This controller will consist of an online interface that anticipates human movement based on high-density electromyography (HD-EMG) recordings, and then translates it into functional assistance. This study will be carried out in both healthy participants and participants post-stroke.The researchers will develop an online algorithm (decoder) in currently existing exoskeletons that can extract hundreds of motor unit (MU) spiking activity out of HD-EMG recordings. The MU spiking activity is a train of action potentials coded by its timing of occurrence that gives access to a representative part of the neural code of human movement. The researchers will also develop a command encoder that can anticipate human intent (multi-joint position and force commands) from MU spiking activity to translate the neural information to movement. The researchers will integrate the decoder with the command encoder to showcase the real-time control of multiple joint lower-limb exoskeletons.

Research Team

José L. Pons, PhD

Jose Pons, Ph.D

Principal Investigator

Shirley Ryan AbilityLab

Eligibility Criteria

This trial is for adults aged 18-80 with normal movement in their limbs, no brain/skull lesions, correctable hearing and vision. It includes stroke survivors who had a unilateral, supratentorial stroke over 6 months ago without other neurological disorders.

Inclusion Criteria

I have never had a brain or skull lesion.
I had a stroke in the upper part of my brain more than 6 months ago.
My hearing and vision are normal or corrected to normal.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Experiment A

Muscle activity data collection via HD-EMG from healthy and post-stroke participants during single-joint and locomotor tasks

4-6 weeks
Multiple sessions for data collection

Experiment B

Calibration and real-time assistance with exoskeleton for healthy and post-stroke participants, including multiple sessions to evaluate decoder stability

10 weeks
Up to 10 sessions for post-stroke participants

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Real-time Neuromuscular Control of Exoskeletons
Trial Overview The study tests a new controller for exoskeletons that uses muscle signals to predict movements. Participants will perform various muscle contractions and activities while wearing an exoskeleton that's guided by this technology.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Healthy ParticipantsExperimental Treatment5 Interventions
The investigators will look at muscle activity of healthy participants from eight lower limb muscles during functional tasks (e.g. single-joint movement, walking, squatting, cycling).
Group II: Clinical ParticipantsExperimental Treatment5 Interventions
The investigators will look at muscle activity of participants post-stroke from eight lower limb muscles during functional tasks (e.g. single-joint movement, walking, squatting, cycling).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Shirley Ryan AbilityLab

Lead Sponsor

Trials
212
Recruited
17,900+

Findings from Research

Exoskeleton-assisted gait training using the Healbot G significantly increased cortical activity in stroke patients compared to traditional treadmill training, indicating enhanced brain engagement during rehabilitation.
Patients in the Healbot G group showed significant improvements in walking ability, balance, and lower limb strength, demonstrating the efficacy of exoskeleton training in enhancing recovery post-stroke.
Effects of Training with a Powered Exoskeleton on Cortical Activity Modulation in Hemiparetic Chronic Stroke Patients: A Randomized Controlled Pilot Trial.Yoo, M., Chun, MH., Hong, GR., et al.[2023]
The Harmony exoskeleton was tested with five stroke survivors over seven hours of therapy, allowing them to perform 1130 motions without any reported adverse effects, indicating its safety for clinical use.
The device not only assists in rehabilitation but also helps therapists assess motor function and develop personalized therapy plans, showing promise for improving upper-limb coordination and function in stroke patients.
Exploring the Capabilities of Harmony for Upper-Limb Stroke Therapy.Oliveira, AC., Rose, CG., Warburton, K., et al.[2020]
The study involving 46 subacute stroke patients demonstrated that overground exoskeleton-assisted gait training (OEAGT) significantly improved clinical and gait outcomes, with many patients regaining the ability to walk after treatment.
Patients reported a positive acceptance of the OEAGT, indicating its potential as an innovative rehabilitation strategy, although further randomized studies with larger samples are needed to confirm these findings.
Overground wearable powered exoskeleton for gait training in subacute stroke subjects: clinical and gait assessments.Goffredo, M., Guanziroli, E., Pournajaf, S., et al.[2020]

References

Effects of Training with a Powered Exoskeleton on Cortical Activity Modulation in Hemiparetic Chronic Stroke Patients: A Randomized Controlled Pilot Trial. [2023]
Exploring the Capabilities of Harmony for Upper-Limb Stroke Therapy. [2020]
Overground wearable powered exoskeleton for gait training in subacute stroke subjects: clinical and gait assessments. [2020]
Mechanics and energetics of post-stroke walking aided by a powered ankle exoskeleton with speed-adaptive myoelectric control. [2020]
Delayed Muscle Activity in Stroke Survivors with Upper-Limb Hemiparesis. [2023]
Powered robotic exoskeletons in post-stroke rehabilitation of gait: a scoping review. [2023]
Effects of an exoskeleton-assisted gait training on post-stroke lower-limb muscle coordination. [2021]
The eWrist - A wearable wrist exoskeleton with sEMG-based force control for stroke rehabilitation. [2018]
Simulation on the Effect of Gait Variability, Delays, and Inertia with Respect to Wearer Energy Savings with Exoskeleton Assistance. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Proportional EMG control for upper-limb powered exoskeletons. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security